Histological Spectrum and Classification of Gastric and Gastro-Oesophageal Junction Cancers in South-East Nigeria: A Retrospective Study
Abstract
Background:
Gastric and gastro-oesophageal junction cancers encompass a heterogeneous group of malignancies with distinct histological and biological characteristics. Histological classification remains central to diagnosis, prognostication, and therapeutic decision-making, particularly in settings where molecular profiling is not routinely available.
Objective:
This study examined the histological spectrum and classification patterns of gastric and gastro-oesophageal junction cancers diagnosed over a ten-year period in Anambra State, South-East Nigeria.
Methods:
A retrospective review was conducted of gastric and gastro-oesophageal junction cancer cases diagnosed between January 2011 and December 2020 across four major histopathology laboratories in Anambra State. Archived haematoxylin and eosin–stained slides and paraffin blocks were reviewed. Tumours were classified according to the 2019 World Health Organization classification of gastric tumours, with carcinomas further categorised using the Lauren classification system. Descriptive statistics and chi-square testing were applied, with statistical significance set at p < 0.05.
Results:
Ninety-three cases met inclusion criteria. Carcinomas constituted the majority of tumours, followed by mesenchymal tumours, lymphomas, and neuroendocrine tumours. Tubular adenocarcinoma was the most frequent carcinoma subtype, while intestinal-type carcinoma predominated under the Lauren classification. Most graded carcinomas were well differentiated. No statistically significant associations were identified between histological subtype and patient age or sex.
Conclusion:
Gastric and gastro-oesophageal junction cancers in this setting are dominated by epithelial malignancies, particularly tubular and intestinal-type adenocarcinomas. The observed histological profile aligns with patterns reported across Nigeria and other low- and middle-income settings, underscoring the continuing relevance of morphology-based classification in regional cancer practice.
Keywords
Downloads
References
- Costache, S., Sajin, M., Wedden, S., & D’Arrigo, C. (2023). A consolidated working classification of gastric cancer for histopathologists. Biomedical Reports, 19(2), 1–8. https://doi.org/10.3892/br.2023.1640
- Cree, I., Carneiro, F., Washington, K., Schirmacher, P., Rugge, M., Paradis, V., Klimstra, D., Odze, R., & Nagtegaal, I. (2020). The 2019 WHO classification of tumours of the digestive system. Histopathology, 76(2), 182–188. https://doi.org/10.1111/his.13975
- Ezejiofor, I. F., Olaofe, O. O., Ezejiofor, O. I., Ukah, C. O., Ozor, N. S., & Osonwa, C. N. (2024). Histopathologic spectrum of lymph node lesions in a teaching hospital in East Nigeria. A nine-year review. Orient Journal of Medicine, 36(1-2), 1-10.
- Gbaa, L. Z., Ojo, B. A., Eke, B. A., Anenga, R. N., Umobong, E. O., & Unande, H. M. (2025). Gastric cancer burden in Northern Nigeria: A retrospective study of 10 years. Journal of Advances in Medical and Pharmaceutical Sciences, 27(6). https://doi.org/10.9734/jamps/2025/v27i6789
- Lam, A. K. Y. (2021). Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice. Human Pathology, 108, 100-112.
- Lauren, P. (1965). The two histological main types of gastric carcinoma: Diffuse and so called intestinal type carcinoma. Acta Pathologica Microbiologica Scandinavica, 64, 31–49.
- Morgan, E., Arnold, M., Camargo, M. C., Gini, A., Kunzmann, A. T., Matsuda, T., ... & Soerjomataram, I. (2022). The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: a population-based modelling study. EClinicalMedicine, 47.
- Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., ... & Cree, I. A. (2019). The 2019 WHO classification of tumours of the digestive system. Histopathology, 76(2), 182.
- Okuchukwu, E.H. and O. A. Olayiwola, (2015) Epidemiology and clinicopathological characteristics of gastric cancer--the Nigerian setting in view. Niger J Med. 2015 Jan-Mar;24(1):71-80. PMID: 25807678.
- Osinowo AO, Olajide TO, Balogun OS, Makanjuola A, Adesanya AA, Atoyebi OA., (2023) Clinicopathological Features and Treatment Outcome of Patients with Gastric Cancer in Lagos: Is the Outlook Getting Better? J West Afr Coll Surg. 2023 Jan-Mar;13(1):67-73. https://doi.org/10.4103/jwas.jwas_219_22.
- Ray Offor, E., & Obiorah, C. C. (2021). Topography and morphology of gastric cancer in Nigeria: A dual institution review of 622 upper gastrointestinal endoscopies. Cureus, 13(8), e14693. https://doi.org/10.7759/cureus.14693
- Sabageh, D., Ojo, O. S., & Adelusola, K. A. (2023). Gastric carcinoma: A review of the histopathological features of cases seen at Ile Ife, Nigeria. Annals of Tropical Pathology, 14(1), 1–8. https://www.ajol.info/index.php/atp/article/view/275020
- Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
- Tagar, E., Irabor, D., Kpolugbo, J., Owobu, C., & Chukwu, I. (2025). Pattern of gastrointestinal malignancies in a suburban centre in Southern Nigeria. African Health Sciences, 25(1), 343-359.
- Webster, A. J., Gaitskell, K., Turnbull, I., Cairns, B. J., & Clarke, R. (2021). Characterisation, identification, clustering, and classification of disease. Scientific Reports, 11(1), 5405.
- Wong, M. C., Huang, J., Chan, P. S., Choi, P., Lao, X. Q., Chan, S. M., ... & Liang, P. (2021). Global incidence and mortality of gastric cancer, 1980-2018. JAMA network open, 4(7), e2118457-e2118457.
- Yibrehu B, Mohammed TO, Murthy S, Aderibigbe AS, Daramola OB, Arije O, Owoade I, Wuraola FO, Olasehinde O, Betiku O, Folorunso SA, Omoyiola O, Aderounmu A, Adisa AO, Kingham PT, Alatise OI. Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences with Establishing an Institutional Cancer Registry. J Surg Oncol. 2025 Mar;131(4):630-636. https://doi.org/10.1002/jso.27993.